Ramucirumab

Product Name: Ramucirumab
CAS No.: 947687-13-0
Chemical Name: Ramucirumab
Synonyms: Cyramza;LY3009806;IMC-1121B;Ramucirumab;Ramucirumab (anti-VEGFR2);Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor
CBNumber: CB72738188
Formula Weight: 0
MOL File: Mol file

More

Less

Ramucirumab Property

storage temp.: Store at -20°C
solubility: Soluble in DMSO
form: Liquid
color: Colorless to light yellow

More

Less

Safety

Hazardous Substances Data: 947687-13-0(Hazardous Substances Data)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

ChemScene

Product number: CS-0031056
Product name: Ramucirumab
Packaging: 1mg
Price: $400
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 1mg
Price: $425
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: ATB0023429
Product name: RAMUCIRUMAB
Purity: 95.00%
Packaging: 5MG
Price: $498.75
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 2mg
Price: $650
Updated: 2021/12/16

Biosynth Carbosynth

Product number: FR159043
Product name: Ramucirumab
Packaging: 5mg
Price: $1000
Updated: 2021/12/16

More

Less

Ramucirumab Chemical Properties,Usage,Production

Clinical Use

Human monoclonal antibody:
Treatment of advanced gastric cancer or gastrooesophageal junction adenocarcinoma, colorectal cancer and non-small cell lung cancer (NSLC)

target

VEGFR2

Drug interactions

Potentially hazardous interactions with other drugs
Vaccines: risk of generalised infections with live vaccines - avoid.

Metabolism

The metabolism of ramucirumab has not been studied. Monoclonal antibodies are mainly cleared by catabolism.

Ramucirumab Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Ramucirumab Suppliers

China 68 India 2 United Kingdom 1 United States 6 Global 77

Carbosynth

Tel: --
Fax: --
Email: sales@carbosynth.com
Country: United Kingdom
ProdList: 6005
Advantage: 58

947687-13-0, RamucirumabRelated Search:

Adalimumab Ustekinumab Nivolumab Bevacizumab Daratumumab OMALIZUMAB Lambrolizumab Dulaglutide Infliximab Rituximab palivizumab Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer Atezolizumab Denosumab CETUXIMAB Evolocumab ipilimumab Eculizumab

Ramucirumab

Ramucirumab,NSCLC,non–small-cell lung cancer,gastric cancer,Inhibitor,VEGFR,Vascular endothelial growth factor receptor,inhibit,angiogenesis inhibitor

Cyramza

IMC-1121B

LY3009806

Ramucirumab (anti-VEGFR2)

947687-13-0